Финска - Фински - Fimea (Suomen lääkevirasto)

b. braun melsungen ag - tryptophanum,prolinum,lysini acetas,argininum,valinum,tyrosinum,acidum asparticum,threoninum,isoleucinum,phenylalaninum,leucinum,serinum,acidum aminoaceticum,acidum glutamicum,methioninum,alaninum - infuusioneste, liuos - yhdistelmävalmisteet

Финска - Фински - Fimea (Suomen lääkevirasto)

b. braun melsungen ag - triglyserida mediocatenalia,soiae oleum raffinatum,argininum,kalii acetas,prolinum,histapyrrodini hydrochloridum,calcii chloridum dihydricum,natrii chloridum,natrii dihydrogenophosphas dihydricus,tryptophanum,zinci acetas dihydricus,valinum,acidum aminoaceticum,methioninum,lysini hydrochloridum,phenylalaninum,serinum,acidum asparticum,glucosum monohydricum,isoleucinum,leucinum,natrii hydroxidum,acidum glutamicum,magnesii acetas tetrahydricum,omega-3 acidorum triglycerida,natrii acetas trihydricus,threoninum - infuusioneste, emulsio - yhdistelmävalmisteet

Финска - Фински - Fimea (Suomen lääkevirasto)

baxter oy - argininum,magnesii acetas tetrahydricum,natrii chloridum,methioninum,leucinum,acidum asparticum,soiae oleum raffinatum,alaninum,cysteinum,acidum glutamicum,threoninum,olivae oleum raffinatum,tyrosinum,natrii glycerophosphas hydricus,serinum,lysini monohydricum,taurinum,phenylalaninum,acidum aminoaceticum,valinum,tryptophanum,isoleucinum,histidinum,ornithini hydrochloridum,kalii acetas,glucosum monohydricum,prolinum,calcii chloridum dihydricum - infuusioneste, emulsio - yhdistelmävalmisteet

Финска - Фински - Fimea (Suomen lääkevirasto)

b. braun melsungen ag - histidinum,methioninum,isoleucinum,tryptophanum,leucinum,acidum asparticum,argininum,threoninum,serinum,lysini monohydricum,valinum,taurinum,acetylcysteinum,n-acetyltyrosinum,acidum glutamicum,prolinum,phenylalaninum,acidum aminoaceticum - infuusioneste, liuos - 100 mg/ml - aminohapot

Европска Унија - Фински - EMA (European Medicines Agency)

les laboratoires servier - trifluridine, tipiracil hydrochloride - paksusuolen vajaatoiminta - antineoplastiset aineet - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Европска Унија - Фински - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - deucravacitinib - psoriasis - immunosuppressantit - treatment of moderate-to-severe plaque psoriasis in adults.

Европска Унија - Фински - EMA (European Medicines Agency)

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiset aineet - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Европска Унија - Фински - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanooma - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.

Финска - Фински - Adama

adama - florasulaami 2,5 g/l + fluroksipyyri 100 g/l + fluroksipyyri-i-metyyliheptyyliesteri 144 g/l - rikkakasvien torjunta

Финска - Фински - Adama

adama - fludioxonil 50 g/l & tebukonazol 10 g/l - peittausaine